For Practitioners

This section is designed for clinicians and practitioners who work with mold-exposed and biotoxin-affected patients. It brings together clinical education on patient evaluation, interpreting TGF-beta and immune markers, treatment sequencing, and caring for highly sensitive patients.

Assessing the Mold-Exposed Patient

How to Evaluate the Mold-Exposed Patient

Build the exposure timeline, complete a sound standard workup, and understand what urine mycotoxins, CIRS biomarkers, and other specialized tools can and can’t establish.

Read the article →

Interpreting Labs in Mold Illness

Interpreting TGF-Beta and Immune Patterns in Mold Illness

How to read TGF-beta 1, MMP-9, C4a, and related marker clusters as context markers, track trends rather than single values, and avoid overinterpretation.

Read the article →

Treatment Sequencing and Protocol Design

The Order of Operations in Complex Mold and Biotoxin Illness

A flexible sequencing framework, from exposure and elimination to stabilization, binders, colonization, and repair, plus why adding one change at a time matters.

Read the article →

Working With Highly Sensitive Patients

Managing the Highly Sensitive Mold Patient: MCAS and Reactivity

Differentiating MCAS from other causes of reactivity, stabilizing before escalating, low-and-slow dosing, and designing a plan the patient can actually tolerate.

Read the article →

Explore all topics in the Mold & Biotoxin Illness Learning Center.

Ready to Learn More?

For deeper, structured learning, explore our educational courses from Drs. Clayton & Christensen for patients and practitioners.

Connect With Us

Follow our mold and biotoxin education, join the community, and stay connected with Drs. Gail Clayton and Margaret Christensen.

The information in this Learning Center is for educational purposes only and is not intended as medical advice. Please consult a qualified healthcare provider about your individual situation.